YU41717B - Process for obtaining -3-amino-5-(4-pyridyl)-1,2,4-triazol bases - Google Patents

Process for obtaining -3-amino-5-(4-pyridyl)-1,2,4-triazol bases

Info

Publication number
YU41717B
YU41717B YU1587/80A YU158780A YU41717B YU 41717 B YU41717 B YU 41717B YU 1587/80 A YU1587/80 A YU 1587/80A YU 158780 A YU158780 A YU 158780A YU 41717 B YU41717 B YU 41717B
Authority
YU
Yugoslavia
Prior art keywords
triazol
pyridyl
bases
amino
obtaining
Prior art date
Application number
YU1587/80A
Other languages
English (en)
Other versions
YU158780A (en
Inventor
C A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU158780A publication Critical patent/YU158780A/xx
Publication of YU41717B publication Critical patent/YU41717B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU1587/80A 1979-06-18 1980-06-16 Process for obtaining -3-amino-5-(4-pyridyl)-1,2,4-triazol bases YU41717B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/049,737 US4276297A (en) 1979-06-18 1979-06-18 Pyridylaminotriazole therapeutic agents

Publications (2)

Publication Number Publication Date
YU158780A YU158780A (en) 1983-04-30
YU41717B true YU41717B (en) 1987-12-31

Family

ID=21961428

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1587/80A YU41717B (en) 1979-06-18 1980-06-16 Process for obtaining -3-amino-5-(4-pyridyl)-1,2,4-triazol bases
YU2633/82A YU41536B (en) 1979-06-18 1982-11-24 Process for obtaining 3-amino-5-(4-pyridil)-1,2,4-triazole bases

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU2633/82A YU41536B (en) 1979-06-18 1982-11-24 Process for obtaining 3-amino-5-(4-pyridil)-1,2,4-triazole bases

Country Status (24)

Country Link
US (1) US4276297A (xx)
JP (1) JPS565477A (xx)
KR (2) KR840002173B1 (xx)
AR (2) AR225766A1 (xx)
AT (2) AT375655B (xx)
BE (1) BE883859A (xx)
CA (1) CA1140133A (xx)
CH (1) CH644375A5 (xx)
DE (1) DE3022302C2 (xx)
DK (1) DK258180A (xx)
ES (2) ES8105313A1 (xx)
FI (1) FI69842C (xx)
FR (1) FR2459241A1 (xx)
GB (1) GB2053910B (xx)
GR (1) GR68731B (xx)
IE (1) IE49913B1 (xx)
IL (1) IL60332A (xx)
IT (1) IT1140993B (xx)
LU (1) LU82527A1 (xx)
NL (1) NL182641C (xx)
PH (1) PH16875A (xx)
PT (1) PT71399A (xx)
SE (1) SE441745B (xx)
YU (2) YU41717B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR230994A1 (es) * 1981-08-31 1984-08-31 Pfizer Procedimiento para preparar compuesto de 3'-substituido-5'-(2-amino-4-piridil)-1',2',4'-triazol
JP2518515Y2 (ja) * 1993-09-22 1996-11-27 茂郎 槇島 水虫用医療包帯
US9440953B2 (en) * 2014-12-19 2016-09-13 OncoArendi Therapeutics Sp. z o.o. Substituted amino triazoles useful as acidic mammalian chitinase inhibitors
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1925654U (de) 1965-07-23 1965-10-21 Alfons Mann Zusatzeinrichtung fuer vergaser an benzinmotoren zur steigerung der motorenleistung.
CH521419A (de) * 1968-03-01 1972-04-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Azofarbstoffe
GB1264798A (xx) 1968-07-10 1972-02-23
US3647814A (en) * 1969-07-03 1972-03-07 Rohm & Haas Method for preparing 4-substituted-1 2 4-triazoles
NL7112373A (xx) * 1970-09-25 1972-03-28
NL7112372A (xx) * 1970-09-25 1972-03-28
GB1403866A (en) * 1971-12-06 1975-08-28 Wyeth John & Brother Ltd Derivatives of 3-amino-1,2,4-triazoles
US3879404A (en) * 1972-07-07 1975-04-22 John J Baldwin Certain 5-(pyridyl)-3(phenyl)-1,2,4-triazoles
US3873563A (en) * 1972-09-29 1975-03-25 Sakai Chemical Industry Co Method for manufacturing 4-amino-1,2,4-triazoles
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators

Also Published As

Publication number Publication date
SE8004498L (sv) 1980-12-19
ES492522A0 (es) 1981-06-01
CA1140133A (en) 1983-01-25
YU263382A (en) 1983-04-30
US4276297A (en) 1981-06-30
FR2459241A1 (fr) 1981-01-09
DK258180A (da) 1980-12-19
KR840002172B1 (ko) 1984-11-26
IE49913B1 (en) 1986-01-08
BE883859A (fr) 1980-12-17
JPS617426B2 (xx) 1986-03-06
NL182641C (nl) 1988-04-18
AR225766A1 (es) 1982-04-30
ES8201155A1 (es) 1981-12-01
GR68731B (xx) 1982-02-10
AR227436A1 (es) 1982-10-29
GB2053910B (en) 1983-04-20
KR840002173B1 (ko) 1984-11-26
CH644375A5 (fr) 1984-07-31
FR2459241B1 (xx) 1983-06-17
AT375655B (de) 1984-08-27
ES498821A0 (es) 1981-12-01
YU158780A (en) 1983-04-30
NL182641B (nl) 1987-11-16
IE801250L (en) 1980-12-18
DE3022302A1 (de) 1981-01-08
PT71399A (en) 1980-07-01
IL60332A (en) 1983-09-30
SE441745B (sv) 1985-11-04
JPS565477A (en) 1981-01-20
IT8022825A0 (it) 1980-06-17
IT1140993B (it) 1986-10-10
DE3022302C2 (de) 1984-03-01
NL8003496A (nl) 1980-12-22
ATA319280A (de) 1984-01-15
KR840004687A (ko) 1984-10-22
ES8105313A1 (es) 1981-06-01
IL60332A0 (en) 1980-09-16
GB2053910A (en) 1981-02-11
KR830002756A (ko) 1983-05-30
ATA307583A (de) 1984-01-15
PH16875A (en) 1984-04-02
FI69842C (fi) 1986-05-26
FI801929A (fi) 1980-12-19
YU41536B (en) 1987-08-31
FI69842B (fi) 1985-12-31
LU82527A1 (fr) 1981-02-03
AT375656B (de) 1984-08-27

Similar Documents

Publication Publication Date Title
YU289180A (en) Process for preparing alfa-aryl-1h-1,2,4-triazole-1-ethanols
YU43116B (en) Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU145680A (en) Process for obtaining substituted 1,2,4-triazines
YU277482A (en) Process for obtaining new 1,2,4-triazole derivatives
PT72883B (en) Process for preparing antiinflamatory 4,5-diaryl-alpha-(poly- fluoroalxyl)-1h-pyrrole-2-methanamines
DE3070919D1 (en) Process for preparing 1,3,7-trialkylxanthines
PT72176B (en) Process for preparing 2,3-indoledione derivatives
YU42323B (en) Process for obtaining 3,5-dichloraniline
YU298779A (en) Process for preparing 2,6-dialkyl-n-alkoxymethyl-2-chloroacetanilides
DE3162735D1 (en) Process for preparing 2,2,6,6-tetramethyl-4-piperidone
YU259480A (en) Process for obtaining 1,2,4-oxdiaoline-5-one derivatives
PT73016A (en) Process for preparing novel substituted pyrazinyl-1,2,4-oxadiazoles
YU41717B (en) Process for obtaining -3-amino-5-(4-pyridyl)-1,2,4-triazol bases
ZA804171B (en) Method for preparing 1,2-dihydro-2-oxo-5-(pyridinyl)nicotinonitriles
DE3166154D1 (en) Process for preparing 1,2-dimethyl-5-nitroimidazole
HU178253B (en) Process for preparing 1,1,2-triphenyl-propane and -propane derivatives
PT72318B (en) Process for preparing antiinflamatory 4,5-diaryl-alpha-(poly- haloalkyl)-1h-imidazole-2-methanols
YU41282A (en) Process for obtaining 3(4-phenyl-1-piperazino-1-yl)-1,2-propandiole-3-(theophilyne-7-yl)-1-propansulphonate
YU41933B (en) Process for obtaining 6,6-methylene-bis (2,2,4-trimethyl)-1,2-dihydroquinoline derivatives
YU298180A (en) Process for preparing 5,10-dihydroimidazo-2,1-quinazoline
YU41739B (en) Process for obtaining 1,2,4-oxadiazine derivatives
AU514100B2 (en) 3-amino-5-(4-pyridyl)-1,2,4-triazoles
YU166579A (en) Process for preparing new 1-substituted 1,4-benzodiazepine-2-ones
YU166679A (en) Process for preparing new 1-substituted 1,4-benzodiazepine-2-ones
PL116331B2 (en) Process for preparing 2,2,5,9-tetramethyldecadi-4,8-en-1-al